A Value-Based Medicine cost-utility analysis of genetic testing for neovascular macular degeneration

BACKGROUND: There is a dearth of patient, preference-based cost-effectiveness analyses evaluating genetic testing for neovascular age-related macular degeneration (NVAMD). METHODS: A Value-Based Medicine, 12-year, combined-eye model, cost-utility analysis evaluated genetic testing of Category 3 AMD...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Int J Retina Vitreous
Huvudupphovsmän: Brown, Gary C., Brown, Melissa M., Lieske, Heidi B., Lieske, Philip A., Brown, Kathryn S.
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2015
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5088478/
https://ncbi.nlm.nih.gov/pubmed/27847612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40942-015-0016-5
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk